Fabtech Technologies Limited conducted its Q3FY26 earnings conference call on February 10, 2026, providing comprehensive insights into the company's performance and strategic direction. The pharmaceutical engineering company addressed revenue timing challenges while maintaining confidence in its annual guidance and long-term growth trajectory.

Q3FY26 Performance and Revenue Recognition

During the earnings call, management explained that Q3FY26 softness was purely a timing issue rather than demand-related concerns. The company operates on a shipment-based revenue recognition model for its export-oriented design-build projects, which can lead to quarterly fluctuations.

The management emphasized that meaningful project execution was completed during Q3, but shipments and inspections moved into Q4. Additionally, front-loaded costs such as engineering, mobilization, and international business development were absorbed in Q3, while corresponding revenues will be recognized with a lag.

Order Book and Business Pipeline

Fabtech Technologies demonstrated strong business momentum with a robust order book position. As of January 31, 2026, the company's outstanding order book stood at Rs 926.00 crores, reflecting healthy demand for its life sciences infrastructure solutions.

FY26 Guidance and Growth Projections

Despite Q3 timing challenges, management reaffirmed its annual guidance for FY26. The company maintains its focus on yearly performance rather than quarterly fluctuations, given the nature of its project-based business model.

For FY27, the company is targeting 30% year-on-year growth, supported by increasing ticket sizes and expanding market presence across pharmaceutical emerging markets.

Strategic Positioning and Market Focus

Fabtech Technologies positions itself as India's global design-build platform for advanced life sciences infrastructure, focusing on pharmaceutical emerging markets including the Middle East, Africa, Persian Gulf, and GCC regions. The company operates as a turnkey life sciences platform with in-house process air and water manufacturing capabilities.

IPO Proceeds Utilization Update

The earnings call also referenced the company's Q3FY26 monitoring agency report for IPO proceeds utilization. From the gross proceeds of Rs 23,029.65 lakhs raised in September-October 2025, the company utilized Rs 125.00 lakhs during Q3 specifically for general corporate purposes, primarily salary and wages payments. The majority of unutilized proceeds remain strategically deployed in fixed deposits with leading banks, earning returns while preserving capital for future initiatives.

Acquisition Strategy and Future Plans

Management outlined plans for strategic acquisitions, particularly targeting European entities to strengthen conversion rates and market positioning. The company expects to complete acquisitions within the next six months, with a focus on enhancing local presence in key markets and improving win rates from the current 15% to 20-25%.

The company also indicated potential expansion into adjacent sectors such as data centers and food security infrastructure, while maintaining primary focus on the substantial pharmaceutical infrastructure opportunity in emerging markets. Management emphasized building for long-term structural growth rather than quarterly performance, positioning Fabtech Technologies as a key enabler of medicinal independence in emerging geographies.

Fabtech Technologies Limited has made available the audio/video recording of its earnings conference call that was held on February 10, 2026, to discuss the unaudited financial results for the quarter and nine months ended December 31, 2025. The company notified stock exchanges about the recording availability on the same day, maintaining compliance with regulatory requirements.

Conference Call Recording Details

The earnings conference call recording can now be accessed by investors and stakeholders through the company's official channels.

The recording is accessible through a direct link provided by the company and is also available on the financial results section of the company's website at fabtechnologies.com/financial-results/.

Management Participation

The earnings call featured key management personnel who provided comprehensive insights into the financial performance and business operations during the reporting period.

Regulatory Compliance and Communication

The notification was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, referencing the original announcement dated February 05, 2026.

The company has ensured that the recording information is properly documented and made available to investors through multiple channels, including direct communication to stock exchanges and publication on the company website for easy accessibility.